Sponsored by George Fox University
Home Must Reads Lake Oswego biotech company battles critics

Lake Oswego biotech company battles critics

| Print |  Email
Must Reads
Monday, December 03, 2012

Lake Oswego's Galena Biopharma is working toward a breast cancer vaccine, despite a negative online article that sent its stock from $1.98 to $1.40 in one day.

Galena's bouncy ride shows how the fragile existence of a small biotech firm rests on not just research and finance, but perception. And technology means conventional wisdom can change in a heartbeat.

Galena is fighting back, suing the suspected authors and reporting the matter to regulators as a case of stock manipulation.

Its lawsuit accuses the authors of printing falsehoods to wipe out $39 million of Galena's value. But in another sense, the suit aims at the growing role of the Internet in stock trading, where websites let anyone anonymously share analysis, rumors and even misinformation while readers -- and authors -- make money when prices fluctuate.

Read more at OregonLive.com.

{biztweet}galena{/biztweet}

 

More Articles

Why I became an Oregon angel investor

Guest Blog
Monday, July 14, 2014
AngelInvestBY TERRY "STARBUCKER" ST. MARIE

I really didn’t know that much about angel investing, but I did know a lot about the entrepreneurial spirit.


Read more...

Portland: Where young people go to work?

News
Friday, June 06, 2014
UntitledBY KATIE AUSBURGER | OB GUEST CONTRIBUTOR

How to build a hipster-friendly work environment.


Read more...

Risks & rewards of owning triple net investments

Contributed Blogs
Thursday, July 24, 2014
NNNinvestmentBY CLIFF HOCKLEY | OB GUEST CONTRIBUTOR

With the increasing retirements of Baby Boomers, a massive real estate shift has created a significant increase in demand for NNN properties. The result? Increased demand has triggered higher prices and lower yields.


Read more...

Attack of the Robin Sages

Contributed Blogs
Monday, July 07, 2014
070714 thumb linkedinfakesBY TOM COX | OB BLOGGER

Named after the 2010 experiment by Thomas Ryan, "Robin Sages" are fake social media profiles designed to encourage linking and divulging valuable information.


Read more...

Who said we should sell in May?

Contributed Blogs
Friday, July 18, 2014
BullMarketBY JASON NORRIS | OB GUEST CONTRIBUTOR

Back in May, we shared a common Wall Street quote about investing, “Sell in May and go away.” Fast forward to July and the most common question we have been getting from clients is, “When is the market pullback going to occur?”


Read more...

OB Video: Oregon MESA

News
Thursday, June 26, 2014

ThumbOregon Business hosts an informal roundtable discussion about the Oregon MESA (Mathematics, Engineering, Science Achievement) program.


Read more...

OB Video: Building trade ties with the EU

News
Monday, June 16, 2014
BritEmbCampionBY KIM MOORE | OB RESEARCH EDITOR

The Oregon economy could get a boost from a new trade agreement being negotiated between the U.S. and the European Union.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS